Carregant...
Use of a Web-based App to Improve Breast Cancer Symptom Management and Adherence for Aromatase Inhibitors: A Randomized Controlled Feasibility Trial
PURPOSE: For postmenopausal women with hormone receptor-positive breast cancer, long-term use of aromatase inhibitors (AIs) significantly reduces the risk of cancer recurrence and improves survival. Still, many patients are nonadherent due to adverse side effects. We conducted a pilot randomized con...
Guardat en:
| Publicat a: | J Cancer Surviv |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6054536/ https://ncbi.nlm.nih.gov/pubmed/29492753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11764-018-0682-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|